日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking Studies

基于计算对接研究的肌醇磷酸类似物的设计与合成

Peng, Zhenghong; Maxwell, David; Sun, Duoli; Ying, Yunming; Schuber, Paul T Jr; Bhanu Prasad, Basvoju A; Gelovani, Juri; Yung, Wai-Kwan Alfred; Bornmann, William G

Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy

设计和开发用于胰腺癌治疗的S100P抑制剂5-甲基色甘酸钠

Arumugam, Thiruvengadam; Ramachandran, Vijaya; Sun, Duoli; Peng, Zhenghong; Pal, Ashutosh; Maxwell, David S; Bornmann, William G; Logsdon, Craig D

Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers

过氧化氢酶可消除β-拉帕酮诱导的PARP1过度激活介导的NQO1阳性乳腺癌细胞程序性坏死

Bey, Erik A; Reinicke, Kathryn E; Srougi, Melissa C; Varnes, Marie; Anderson, Vernon E; Pink, John J; Li, Long Shan; Patel, Malina; Cao, Lifen; Moore, Zachary; Rommel, Amy; Boatman, Michael; Lewis, Cheryl; Euhus, David M; Bornmann, William G; Buchsbaum, Donald J; Spitz, Douglas R; Gao, Jinming; Boothman, David A

Synthesis of a Macrocycle Based on Linked Amino Acid Mimetics (LAAM)

基于连接氨基酸模拟物(LAAM)的大环化合物的合成

Maxwell, David S; Sun, Duoli; Peng, Zhenghong; Martin, Diana V; Bhanu Prasad, Basvoju A; Bornmann, William G

Asymmetric Synthesis of the C1-C6 Portion of the Psymberin Using an Evans Chiral Auxiliary

利用埃文斯手性辅助剂对Psymberin的C1-C6部分进行不对称合成

Pal, Ashutosh; Peng, Zhenghong; Schuber, Paul T Jr; Bhanu Prasad, Basvoju A; Bornmann, William G

STAT3 mediates resistance to MEK inhibitor through microRNA miR-17.

STAT3 通过 microRNA miR-17 介导对 MEK 抑制剂的耐药性

Dai Bingbing, Meng Jieru, Peyton Michael, Girard Luc, Bornmann William G, Ji Lin, Minna John D, Fang Bingliang, Roth Jack A

Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy

β-拉帕酮胶束纳米疗法用于非小细胞肺癌治疗

Blanco, Elvin; Bey, Erik A; Khemtong, Chalermchai; Yang, Su-Geun; Setti-Guthi, Jagadeesh; Chen, Huabing; Kessinger, Chase W; Carnevale, Kevin A; Bornmann, William G; Boothman, David A; Gao, Jinming

Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.

在体外和体内实验中,MEK 和 AKT 抑制剂联合治疗比单独使用任何一种药物治疗人类非小细胞肺癌都更有效

Meng Jieru, Dai Bingbing, Fang Bingliang, Bekele B Nebiyou, Bornmann William G, Sun Duoli, Peng Zhenghong, Herbst Roy S, Papadimitrakopoulou Vassiliki, Minna John D, Peyton Michael, Roth Jack A

Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells

拉帕替尼的活性与HER2过表达乳腺癌细胞中的EGFR表达水平无关。

Zhang, Dongwei; Pal, Ashutosh; Bornmann, William G; Yamasaki, Fumiyuki; Esteva, Francisco J; Hortobagyi, Gabriel N; Bartholomeusz, Chandra; Ueno, Naoto T

Mechanism of activation and inhibition of the HER4/ErbB4 kinase

HER4/ErbB4激酶的激活和抑制机制

Qiu, Chen; Tarrant, Mary K; Choi, Sung Hee; Sathyamurthy, Aruna; Bose, Ron; Banjade, Sudeep; Pal, Ashutosh; Bornmann, William G; Lemmon, Mark A; Cole, Philip A; Leahy, Daniel J